Cyclo Therapeutics’ Trappsol Cyclo was able to induce clinical improvement in seven out of eight children with Neimann-Pick ...

Lilly has revealed that subjects with Crohn's disease have achieved long-term clinical and endoscopic outcomes with Omvoh in the VIVID-2.

Early detection and public health interventions are critical in improving sepsis survival rates and limiting its long-term ...

The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

Novo Nordisk’s haemophilia A candidate has met the primary endpoints in a Phase III trial. Image credit: Shutterstock / JHVEPhoto Novo Nordisk’s haemophilia A therapy Mim8 stopped bleeding completely ...

Across three cohorts, 26 subjects were enrolled. Credit: New Africa/Shutterstock. Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...

A total of 113 subjects were enrolled in the trial. Credit: SofikoS / Shutterstock. Palatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...